{"title":"在极度早产前24小时至7天期间给予产前皮质类固醇与死亡率最低有关。","authors":"Colm P Travers, Waldemar A Carlo","doi":"10.1136/ebmed-2017-110742","DOIUrl":null,"url":null,"abstract":"Commentary on: Norberg H, Kowalski J, Marsal K, et al. Timing of antenatal corticosteroid administration and survival in extremely preterm infants: a national population-based cohort study. BJOG 2017. doi: 10.1111/1471-0528.14545. [Epub ahead of print 15 March 2017].\n\nAntenatal corticosteroids (ACS) reduce mortality in preterm infants.1 The association between timing of ACS and outcomes among extremely preterm infants has been sparsely investigated. In a recent large retrospective cohort study, higher odds for severe neonatal morbidity or mortality were seen in infants born at 24–33 weeks gestation with an administration-to-birth interval of ACS 7 days compared with 1–7 days.2 The objective of this study was to investigate the impact of ACS administration-to-birth interval on survival among extremely preterm infants.\n\nThis population-based cohort study used data collected prospectively …","PeriodicalId":12182,"journal":{"name":"Evidence-Based Medicine","volume":"22 5","pages":"189"},"PeriodicalIF":0.0000,"publicationDate":"2017-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1136/ebmed-2017-110742","citationCount":"1","resultStr":"{\"title\":\"Antenatal corticosteroid administration between 24 hours and 7 days before extremely preterm delivery is associated with the lowest rate of mortality.\",\"authors\":\"Colm P Travers, Waldemar A Carlo\",\"doi\":\"10.1136/ebmed-2017-110742\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Commentary on: Norberg H, Kowalski J, Marsal K, et al. Timing of antenatal corticosteroid administration and survival in extremely preterm infants: a national population-based cohort study. BJOG 2017. doi: 10.1111/1471-0528.14545. [Epub ahead of print 15 March 2017].\\n\\nAntenatal corticosteroids (ACS) reduce mortality in preterm infants.1 The association between timing of ACS and outcomes among extremely preterm infants has been sparsely investigated. In a recent large retrospective cohort study, higher odds for severe neonatal morbidity or mortality were seen in infants born at 24–33 weeks gestation with an administration-to-birth interval of ACS 7 days compared with 1–7 days.2 The objective of this study was to investigate the impact of ACS administration-to-birth interval on survival among extremely preterm infants.\\n\\nThis population-based cohort study used data collected prospectively …\",\"PeriodicalId\":12182,\"journal\":{\"name\":\"Evidence-Based Medicine\",\"volume\":\"22 5\",\"pages\":\"189\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1136/ebmed-2017-110742\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Evidence-Based Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/ebmed-2017-110742\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2017/7/17 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Evidence-Based Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ebmed-2017-110742","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/7/17 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
Antenatal corticosteroid administration between 24 hours and 7 days before extremely preterm delivery is associated with the lowest rate of mortality.
Commentary on: Norberg H, Kowalski J, Marsal K, et al. Timing of antenatal corticosteroid administration and survival in extremely preterm infants: a national population-based cohort study. BJOG 2017. doi: 10.1111/1471-0528.14545. [Epub ahead of print 15 March 2017].
Antenatal corticosteroids (ACS) reduce mortality in preterm infants.1 The association between timing of ACS and outcomes among extremely preterm infants has been sparsely investigated. In a recent large retrospective cohort study, higher odds for severe neonatal morbidity or mortality were seen in infants born at 24–33 weeks gestation with an administration-to-birth interval of ACS 7 days compared with 1–7 days.2 The objective of this study was to investigate the impact of ACS administration-to-birth interval on survival among extremely preterm infants.
This population-based cohort study used data collected prospectively …
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
